Background A nationwide hepatitis B vaccination program was implemented in Taiwan in
July 1984. To assess the effect of the program on the development of hepatocellular …

Objective. In 1984, Taiwan started a large-scale hepatitis B vaccination program, enabling
us to test the hypothesis that prevention of hepatitis B virus infection eventually decreases …

The world's first nationwide hepatitis B virus (HBV) universal vaccination program for infants
was launched in Taiwan in July, 1984. All infants received three to four doses plasma or …

Background: Hepatitis B virus infection is one of the most important risk factors for
hepatocellular carcinoma. Hepatitis B vaccination has been obligatory in the Expanded …

In July 1984, large-scale hepatitis B vaccination of newborns began in Taiwan. Vaccination
decreased the overall incidence of childhood hepatocellular carcinoma (HCC). We …

Purpose: In spite of the success of hepatitis B immunization, still a significant proportion of
childhood hepatocellular carcinoma (HCC) failed to be prevented by the hepatitis B …

ContextHepatocellular carcinoma (HCC) has a male predominance and is closely related to
hepatitis B virus (HBV) infection. Hepatitis B virus vaccination was launched in 1984 in …

Acute and chronic hepatitis B virus (HBV) infection is a leading cause of liver disease
worldwide. It is estimated that approximately 350 million people worldwide have chronic …

Hepatocellular carcinoma (HCC) is one of the 10 most common malignant tumors
worldwide. Chronic infection with hepatitis B or C virus is closely related to …

Hepatitis B virus (HBV) infection is an important global health problem. It is a major cause of
chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). 1 It is prevalent in …